These copper-dependent activities support several processes fundamental to cancer cell survival and progression.1 Increased copper import through CTR1 could enhance the activity of these or other copper-dependent pathways, contributing to metabolic fitness, redox stability, autophagy regulation, and ECM remodeling, processes that may collectively promote aggressive tumor behavior and could attenuate chemotherapy efficacy. The gene discussed is SLC31A1; the disease is neoplasm.